Al Rabadi Anas, Al Kofahi Ahmad, Albudour Laith, Abushqair Mansour, Harahsheh Taher, Al-Harahsheh Hend, Al-Shurbaji Duaa
Department of Surgery, Jordanian Royal Medical Services, Amman, JOR.
Department of Surgery, Royal Medical Services, Amman, JOR.
Cureus. 2024 Jul 29;16(7):e65674. doi: 10.7759/cureus.65674. eCollection 2024 Jul.
Metaplastic breast carcinoma (MBC) represents a rare subtype of breast cancer, characterized by poor prognostic indicators that have been recently identified. Clinical and radiological presentations often mimic other breast cancer types, necessitating immunohistochemistry (IHC) for accurate diagnosis. In this study, we report a case involving a 31-year-old female presenting with a painless, fixed, non-inflammatory mass in the left breast, which was confirmed as MBC. Treatment encompassed lumpectomy, chemotherapy, radiotherapy, and subsequent hormonal therapy. Understanding this rarely reported yet aggressive form of breast cancer holds significant importance for clinicians, enabling them to promptly establish a diagnosis and implement effective management strategies.
化生性乳腺癌(MBC)是一种罕见的乳腺癌亚型,其特征是最近发现的预后指标较差。临床和影像学表现通常与其他类型的乳腺癌相似,因此需要进行免疫组织化学(IHC)检查以准确诊断。在本研究中,我们报告了一例病例,患者为一名31岁女性,左乳出现无痛、固定、非炎性肿块,经确诊为化生性乳腺癌。治疗包括肿块切除术、化疗、放疗及后续的激素治疗。了解这种报道较少但侵袭性强的乳腺癌形式对临床医生至关重要,有助于他们迅速做出诊断并实施有效的管理策略。